Order Article Reprints

Shulskaya MV, Semenova EI, Rudenok MM, Partevian SA, Lukashevich MV, Karabanov AV, Fedotova EY, Illarioshkin SN, Slominsky PA, Shadrina MI, et al. Analysis of LRRN3, MEF2C, SLC22A, and P2RY12 Gene Expression in the Peripheral Blood of Patients in the Early Stages of Parkinson’s Disease. Biomedicines. 2024; 12(7):1391. https://doi.org/10.3390/biomedicines12071391

Shulskaya, Marina V., Ekaterina I. Semenova, Margarita M. Rudenok, Suzanna A. Partevian, Maria V. Lukashevich, Alexei V. Karabanov, Ekaterina Yu. Fedotova, Sergey N. Illarioshkin, Petr A. Slominsky, Maria I. Shadrina, and et al. 2024. "Analysis of LRRN3, MEF2C, SLC22A, and P2RY12 Gene Expression in the Peripheral Blood of Patients in the Early Stages of Parkinson’s Disease" Biomedicines 12, no. 7: 1391. https://doi.org/10.3390/biomedicines12071391

Shulskaya, M. V., Semenova, E. I., Rudenok, M. M., Partevian, S. A., Lukashevich, M. V., Karabanov, A. V., Fedotova, E. Y., Illarioshkin, S. N., Slominsky, P. A., Shadrina, M. I., & Alieva, A. K. (2024). Analysis of LRRN3, MEF2C, SLC22A, and P2RY12 Gene Expression in the Peripheral Blood of Patients in the Early Stages of Parkinson’s Disease. Biomedicines, 12(7), 1391. https://doi.org/10.3390/biomedicines12071391